CLEVELAND (AP) — CLEVELAND (AP) — Abeona Therapeutics Inc. (ABEO) on Thursday reported second-quarter net income of $108.8 million.
On a per-share basis, the Cleveland-based company said it had net income of $1.71.
The results beat Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 39 cents per share.
The drug developer posted revenue of $400,000 in the period.
Abeona Therapeutics shares have increased 18% since the beginning of the year. The stock has climbed 32% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABEO at https://www.zacks.com/ap/ABEO
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
